ஃபெடெக்ஸ் ப்ரையாரிடீ எச்சரிக்கை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஃபெடெக்ஸ் ப்ரையாரிடீ எச்சரிக்கை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஃபெடெக்ஸ் ப்ரையாரிடீ எச்சரிக்கை Today - Breaking & Trending Today

FedEx Prepares For COVID-19 Vaccine Volume Growth, Begins Shipping Newly Approved Vaccine


Bookmark of this page has been deleted.
FedEx Prepares For COVID-19 Vaccine Volume Growth, Begins Shipping Newly Approved Vaccine
FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the world’s largest express transportation company, announced today that it has begun shipping the newly approved COVID-19 vaccine on behalf of McKesson Corp. to dosing centers throughout the United States.
The company has shipped millions of COVID-19 vaccines since U.S. distribution began in mid-December 2020 and is prepared to scale up to accommodate anticipated growth in vaccine volume throughout the spring and summer. Nearly three months after COVID-19 vaccine distribution began, FedEx has shipped COVID-19 vaccines and supply kits to administration sites across all 50 states, Puerto Rico, the U.S. Virgin Islands, and Washington, D.C. COVID-19 vaccine volume is split evenly with FedEx moving approximately half the doses allocated by the federal government. ....

Puerto Rico , United States , Don Colleran , Richardw Smith , Mckesson Corp , Fedex Corp , Pfizer Inc , International Medical Corps , Defense Logistics Agency , Heart To International , Fedex Express , Fedex Priority , Direct Relief , Fedex Priority Overnight , Fedex Priority Alert , Fedex Surround , ப்வெர்டோ ரிக்கோ , ஒன்றுபட்டது மாநிலங்களில் , தாதா கூட்டு , ம்க்கேஸ்சொன் கார்ப் , ஃபெடெக்ஸ் கார்ப் , ஃபைசர் இன்க் , சர்வதேச மருத்துவ கார்ப்ஸ் , இதயம் க்கு சர்வதேச , ஃபெடெக்ஸ் எக்ஸ்பிரஸ் , ஃபெடெக்ஸ் ப்ரையாரிடீ ,

Janssen's COVID-19 vaccine gets emergency use authorization, shipments begin


Senior Editor
The Food and Drug Administration on Sunday granted emergency use authorization to Johnson & Johnson s Janssen single dose COVID-19 vaccine for use in individuals 18 years of age and older, making it the third vaccine to prevent COVID-19 that has been cleared for use in the United States.
The shipment of 3.9 million doses of Janssen s COVID-19 vaccine began today. Some 800,000 of those doses are expected to go directly to pharmacies, according to an ABC News report. 
J&J said it expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20 million people in the United States. The company plans to deliver 100 million single-shot vaccines to the U.S. during the first half of 2021. ....

United States , Puerto Rico , Paul Stoffels , Johnson Janssen , Peter Marks , Janet Woodcock , Don Colleran , Drug Administration On , Drug Administration , Fedex Priority Overnight , Fedex Priority Alert , Emergency Use Authorization , Biologics Evaluation , ஒன்றுபட்டது மாநிலங்களில் , ப்வெர்டோ ரிக்கோ , ஜான்சன் ஜான்சன் , பீட்டர் மதிப்பெண்கள் , ஜேனட் மரக்கட்டை , தாதா கூட்டு , ஃபெடெக்ஸ் ப்ரையாரிடீ ஓவர்‌நைட் , ஃபெடெக்ஸ் ப்ரையாரிடீ எச்சரிக்கை , அவசரம் பயன்பாடு அங்கீகாரம் , உயிரியல் மதிப்பீடு ,